Validation of EuroSCORE II in Chinese Patients Undergoing Heart Valve Surgery

Zhang, Guanxin; Wang, Chong; Lv, Wang; Lu, Fanglin; Li, Bailing; Han, Lin; Zhao, Xu

doi:10.1016/j.hlc.2012.12.012

Cited by 34 publications

(31 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(23) In another study comparing the EuroSCORE II in a Turkish cohort of 428 patients, the model was shown to underestimate mortality risk for the entire cohort. (24) Our study cohort, though small, showed a similar pattern with the predicted mortality being underestimated in the entire cohort but overestimated in the lower risk AVR and MV repair groups.…”

Section: Infective Endocarditismentioning

confidence: 99%

Long term outcome and EuroSCORE II validation in native valve surgery for active infective endocarditis in a South African cohort

Koshy

Engel

Carrara

et al. 2018

SAHJ

View full text Add to dashboard Cite

There has been little change in the mortality from infective endocarditis, despite the diagnostic and therapeutic advances made in the last 25 years. The current in-hospital mortality rate for patients with IE is 15% -20%, with 1-year mortality approaching 40%. The morbidity associated with infective endocarditis includes: valvular incompetence, embolisation, cerebrovascular accidents and congestive heart failure which have influenced the surgical approaches to a great extent. Infective endocarditis is a significant problem in sub-Saharan Africa and is related to a high prevalence of rheumatic heart disease among the young indigent population. Africa has the highest burden of rheumatic heart disease contributing 17% -43% of all heart disease.

show abstract

Section: Infective Endocarditismentioning

confidence: 99%

Long term outcome and EuroSCORE II validation in native valve surgery for active infective endocarditis in a South African cohort

Koshy

Engel

Carrara

et al. 2018

SAHJ

View full text Add to dashboard Cite

show abstract

“…en algunos de los artículos se hace distinción entre la cirugía con y sin circulación extracorpórea 259 ; en otros se distinguen las cirugías valvulares dependiendo de cual sea la válvula intervenida 202,257,272 ; y, en artículos basados en el análisis de predictores de estancias prolongadas en UCIs y complicaciones postoperatorias se ha preferido describir todos los tipos de cirugías sin intentar agrupar en grupos más generales 232,260 .…”

Section: Discussionunclassified

“…En los artículos publicados en España sobre este tema, En cuanto al SAPS III, son pocos las publicaciones en las que vemos la utilización de esta escala en la población sometida a cirugía cardiaca, ya que como hemos podido comprobar los resultados obtenidos no corresponden con los observados en la realidad, no es una escala diseñada específicamente para cirugía cardiaca y la discriminación observado es pobre. 272 . También se ha observado mejor poder de discriminación cuando la etiología de la patología valvular es no reumática en comparación con la patología valvular de origen reumático 270 .…”

Section: Discussionunclassified

“…Estos datos son semejantes a los encontrados en zonas de UK como los publicados por un grupo de trabajo de Liverpool (71% de cirugía programada) 254 y los publicados en Hungría donde el 74,1% de las cirugías fueron programadas 243 . Sin embargo son menores que los encontrados en otras zonas europeas, como regiones del sur de Italia donde el 80% de la cirugía se lleva a cabo de manera programada 244 , o en grupos de pacientes específicos, como los pacientes sometidos a cirugía valvular aórtica en Milán donde el 98% de las operaciones son programadas 257 , o pacientes valvulares en China ( 99%) 272 . En países como Irán el 93,4% de las cirugías cardiacas se realizan de manera programada 273 .…”

Section: Se Muestra Las Curvas De Calibración Con El 95% Del Intervalunclassified

See 1 more Smart Citation

Valoración del Euroscore y SAPS III como predictor de mortalidad hospitalaria en el postoperatorio de cirugía cardiaca

Mateos-Pañero

Sánchez-Casado

Castaño-Moreira

et al. 2017

Revista Española de Anestesiología y Reanimación

View full text Add to dashboard Cite

“…Similar differences combined with altered risk-adjusted mortality were also found in China and India when compared with that of STS and EuroSCORE II sample population undergoing valve surgeries. [101415] It is recommended that each population validates its own cardiac surgical patient subject. EuroSCORE, after all, is not meant to be universal, but just a guide.…”

Section: Nonmodifiable Factorsmentioning

confidence: 99%

Modifying risks to improve outcome in cardiac surgery: An anesthesiologist's perspective

Chakravarthy

2017

Ann Card Anaesth

View full text Add to dashboard Cite

Challenging times are here for cardiac surgical and anesthesia team. The interventional cardiologist seem to have closed the flow of ‘good cases’ coming up for any of the surgery,; successful percutaneous interventions seem to be offering reasonable results in these patients, who therefore do not knock on the doors of the surgeons any more. It is a common experience among the cardiac anesthesiologists and surgeons that the type of the cases that come by now are high risk. That may be presence of comorbidities, ongoing medical therapies, unstable angina, uncontrolled heart failure and rhythm disturbances; and in patients with ischemic heart disease, the target coronaries are far from ideal. Several activities such as institution of preoperative supportive circulatory, ventilatory, and systemic disease control maneuvers seem to have helped improving the outcome of these ‘high risk ‘ patients. This review attempts to look at various interventions and the resulting improvement in outcomes. Several changes have happened in the realm of cardiac surgery and several more are en route. At times, for want of evidence, maximal optimization may not take place and the patient may encounter unfavorable outcomes.. This review is an attempt to bring the focus of the members of the cardiac surgical team on the value of preoperative optimization of risks to improve the outcome. The cardiac surgical patients may broadly be divided into adults undergoing coronary artery bypass graft surgery, valve surgery and pediatric patients undergoing repair/palliation of congenital heart ailments. Optimization of risks appear to be different in each genre of patients. This review also brings less often discussed issues such as anemia, nutritional issues and endocrine problems. The review is an attempt to data on ameliorating modifiable risk factors and altering non modifiable ones.

show abstract

Validation of EuroSCORE II in Chinese Patients Undergoing Heart Valve Surgery

Cited by 34 publications

References 13 publications

Long term outcome and EuroSCORE II validation in native valve surgery for active infective endocarditis in a South African cohort

Long term outcome and EuroSCORE II validation in native valve surgery for active infective endocarditis in a South African cohort

Valoración del Euroscore y SAPS III como predictor de mortalidad hospitalaria en el postoperatorio de cirugía cardiaca

Modifying risks to improve outcome in cardiac surgery: An anesthesiologist's perspective

Contact Info

Product

Resources

About